NCT01885182 2019-10-04
Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Completed
Clinical Trials
5 trialsNCT00513656 2018-10-23
A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain
Mundipharma Research GmbH & Co KG
Phase 2 Completed
NCT01313780 2017-12-22
TOP
Mundipharma Korea Ltd
Phase 4 Completed
NCT01675531 2016-12-16
A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Mundipharma Korea Ltd
Phase 4 Completed
NCT02321397 2016-11-04
To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
Mundipharma Research GmbH & Co KG
Phase 2/3 Completed